Skip to main content
. 2023 Aug 18;15(16):4169. doi: 10.3390/cancers15164169

Figure 3.

Figure 3

Distribution of CTC phenotypes in breast cancer patients: Distribution of exclusive and dominant CTC phenotypes in the whole cohort of patients and among different molecular subtypes of breast cancer (A), and heterogeneity of CTCs in individual patients with CTC ≥ 5 (B).